Literature DB >> 8039884

Inhibition of binding, entry, or intracellular proliferation of Ehrlichia risticii in P388D1 cells by anti-E. risticii serum, immunoglobulin G, or Fab fragment.

J B Messick1, Y Rikihisa.   

Abstract

The effects of equine antiserum, immunoglobulin G (IgG) specific for Ehrlichia risticii, and its Fab fragment on E. risticii binding to, internalization into, and proliferation in P388D1 cells were studied by immunofluorescence flow cytometry. Anti-E. risticii equine serum or IgG inhibited E. risticii at a stage beyond binding and internalization. In contrast, monovalent anti-E. risticii equine Fab fragments inhibited E. risticii binding and internalization into P388D1 cells. In the presence of control equine serum, IgG, or its Fab fragment, E. risticii cells were bound, were internalized and subsequently grew within P388D1 cells, and eventually destroyed the host cells as effectively as was the case without equine serum, IgG, or Fab fragments. Anti-E. risticii IgG but not normal horse IgG inhibited L-[14C]glutamine metabolism in Percoll gradient-purified E. risticii. These findings suggest that the Fab fragment of intact anti-E. risticii IgG blocks the ligands on E. risticii responsible for non-IgG-mediated internalization and diverts them to bind via the Fc receptor. Following Fc-mediated entry of E. risticii, the antibody interfered with the metabolic activity of E. risticii cells, rendering them incapable of proliferation in P388D1 cells and resulting in the eventual destruction of the organisms.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8039884      PMCID: PMC302940          DOI: 10.1128/iai.62.8.3156-3161.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Passive transfer of antibody to Ehrlichia risticii protects mice from ehrlichiosis.

Authors:  P S Kaylor; T B Crawford; T F McElwain; G H Palmer
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

2.  Serosurvey of horses with evidence of equine monocytic ehrlichiosis.

Authors:  Y Rikihisa; S M Reed; R A Sams; J C Gordon; C I Pretzman
Journal:  J Am Vet Med Assoc       Date:  1990-11-15       Impact factor: 1.936

3.  Presence of parasite antigen on the surface of P388D1 cells infected with Ehrlichia risticii.

Authors:  J B Messick; Y Rikihisa
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

4.  Enzyme-linked immunosorbent assay for Potomac horse fever disease.

Authors:  C I Pretzman; Y Rikihisa; D Ralph; J C Gordon; S Bech-Nielsen
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

5.  Protection against murine potomac horse fever by an inactivated Ehrlichia risticii vaccine.

Authors:  Y Rikihisa
Journal:  Vet Microbiol       Date:  1991-05       Impact factor: 3.293

6.  Substrate utilization by Ehrlichia sennetsu and Ehrlichia risticii separated from host constituents by renografin gradient centrifugation.

Authors:  E Weiss; G A Dasch; Y H Kang; H N Westfall
Journal:  J Bacteriol       Date:  1988-11       Impact factor: 3.490

7.  Lack of lysosomal fusion with phagosomes containing Ehrlichia risticii in P388D1 cells: abrogation of inhibition with oxytetracycline.

Authors:  M Y Wells; Y Rikihisa
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

8.  In vitro killing of Ehrlichia risticii by activated and immune mouse peritoneal macrophages.

Authors:  N M Williams; P J Timoney
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

9.  Energy metabolism of monocytic Ehrlichia.

Authors:  E Weiss; J C Williams; G A Dasch; Y H Kang
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

10.  Reduced immune responsiveness and lymphoid depletion in mice infected with Ehrlichia risticii.

Authors:  Y Rikihisa; G C Johnson; C J Burger
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

View more
  10 in total

Review 1.  Antibody-mediated immunity against intracellular pathogens: two-dimensional thinking comes full circle.

Authors:  Arturo Casadevall
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

2.  Association of deficiency in antibody response to vaccine and heterogeneity of Ehrlichia risticii strains with Potomac horse fever vaccine failure in horses.

Authors:  S K Dutta; R Vemulapalli; B Biswas
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

3.  Protein kinase A-mediated inhibition of gamma interferon-induced tyrosine phosphorylation of Janus kinases and latent cytoplasmic transcription factors in human monocytes by Ehrlichia chaffeensis.

Authors:  E H Lee; Y Rikihisa
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

4.  Anti-Ehrlichia chaffeensis antibody complexed with E. chaffeensis induces potent proinflammatory cytokine mRNA expression in human monocytes through sustained reduction of IkappaB-alpha and activation of NF-kappaB.

Authors:  E H Lee; Y Rikihisa
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

5.  Porin activity of Anaplasma phagocytophilum outer membrane fraction and purified P44.

Authors:  Haibin Huang; Xueqi Wang; Takane Kikuchi; Yumi Kumagai; Yasuko Rikihisa
Journal:  J Bacteriol       Date:  2006-12-15       Impact factor: 3.490

6.  Proteomic analysis of Neorickettsia sennetsu surface-exposed proteins and porin activity of the major surface protein P51.

Authors:  Kathryn Gibson; Yumi Kumagai; Yasuko Rikihisa
Journal:  J Bacteriol       Date:  2010-09-10       Impact factor: 3.490

7.  Human granulocytic ehrlichiosis agent and Ehrlichia chaffeensis reside in different cytoplasmic compartments in HL-60 cells.

Authors:  J Mott; R E Barnewall; Y Rikihisa
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

8.  Pathogenic, immunologic, and molecular differences between two Ehrlichia risticii strains.

Authors:  R Vemulapalli; B Biswas; S K Dutta
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

9.  Lambs immunized with an inactivated variant of Anaplasma phagocytophilum.

Authors:  Snorre Stuen; Wenche Okstad; Karin Artursson; Basima Al-Khedery; Anthony Barbet; Erik G Granquist
Journal:  Acta Vet Scand       Date:  2015-07-25       Impact factor: 1.695

10.  Anaplasma phagocytophilum MSP4 and HSP70 Proteins Are Involved in Interactions with Host Cells during Pathogen Infection.

Authors:  Marinela Contreras; Pilar Alberdi; Lourdes Mateos-Hernández; Isabel G Fernández de Mera; Ana L García-Pérez; Marie Vancová; Margarita Villar; Nieves Ayllón; Alejandro Cabezas-Cruz; James J Valdés; Snorre Stuen; Christian Gortazar; José de la Fuente
Journal:  Front Cell Infect Microbiol       Date:  2017-07-05       Impact factor: 5.293

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.